Vista Finance LLC Sells 170 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

by · The Markets Daily

Vista Finance LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 4.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 4,019 shares of the healthcare conglomerate’s stock after selling 170 shares during the quarter. UnitedHealth Group comprises 3.2% of Vista Finance LLC’s holdings, making the stock its 10th largest position. Vista Finance LLC’s holdings in UnitedHealth Group were worth $2,350,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the business. Kathleen S. Wright Associates Inc. purchased a new position in shares of UnitedHealth Group in the third quarter worth $27,000. Global Wealth Strategies & Associates lifted its position in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the period. Macroview Investment Management LLC increased its holdings in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the period. West Financial Advisors LLC purchased a new stake in UnitedHealth Group in the third quarter valued at approximately $32,000. Finally, Delos Wealth Advisors LLC raised its position in UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock opened at $562.13 on Wednesday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The firm has a market capitalization of $519.08 billion, a PE ratio of 36.62, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The business has a 50 day simple moving average of $582.88 and a 200-day simple moving average of $540.32.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. During the same quarter in the previous year, the company posted $6.56 EPS. The company’s revenue was up 9.2% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on UNH shares. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 24th. KeyCorp assumed coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 target price on the stock. Barclays lowered their price objective on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Finally, Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price objective for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $615.53.

View Our Latest Analysis on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).